Navigation Links
Blending conference translates substance abuse research into practice
Date:4/16/2012

Experts will share the latest clinical research with addiction treatment professionals, healthcare providers, policy makers, and others during the April 19th Blending Conference in Atlanta, Georgia. The program is supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, in collaboration with the American Society of Addiction Medicine Annual Medical-Scientific Conference as part of an ongoing initiative to accelerate research findings into practice.

WHAT: Blending Initiative: Accelerating Knowledge Exchange in Substance Abuse Treatment
www.seiservices.com/nida/blending2012/Default.aspx

WHEN: April 19, 2012
8 a.m. 5 p.m.

WHERE: Hilton Atlanta Hotel
255 Courtland St. NE
Atlanta, GA 30303

This year's program includes:

  • Making motivational interviewing techniques accessible to primary care;
  • New approaches to pharmacotherapy for substance use disorders;
  • Screening, brief intervention, referral to treatment (SBIRT): implementation for primary care and/or emergency departments; and
  • HIV testing and intervention in integrated treatment settings.


'/>"/>

Contact: NIDA Press Office
media@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse
Source:Eurekalert

Page: 1

Related medicine news :

1. Custom Blending Announces New Brand Launch: Harmony Valley Vegetarian Mixes at Fancy Food Show, New York City, June 27-29, 2010
2. NJ stroke researchers report advances in spatial neglect research at AAN Conference
3. Elsevier organizes label-free technologies conference
4. Conference explores ethical dimension of NHS
5. Kessler Foundation neuroscientist addresses 2nd Annual TBI Conference in Washington DC
6. Kessler Foundation researchers present at DC Conference on Race, Ethnicity and Disabilities
7. Experts in pediatric heart disease present research at Cardiology 2012 conference
8. TGen hosts international conference for leading pediatric cancer researchers, foundations
9. SFU hits hot buttons at 2012 AAAS conference
10. Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC
11. Kessler Foundations John DeLuca, Ph.D., conducts national MS Society teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the appropriate ... and maintaining GMP and USP compliance. In a new webinar from METTLER TOLEDO ... " these requirements are explained. The challenge is to determine how to ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the release of two biometric time and attendance tracking products: the new NCheck ... software. NCheck Cloud Bio Attendance uses biometric face recognition to enable users to ...
(Date:3/28/2017)... ... March 28, 2017 , ... In ... Self-Funding Success website has recently developed and published an informational resource that addresses ... created based on common inquiries the site’s team of third party administrator (TPA) ...
(Date:3/28/2017)... ... ... A minimally invasive porcelain veneer is increasing in popularity ... Dental Laboratories (NADL) is informing dentists about the benefits of minimally invasive dentistry, ... and technicians that create these veneers. , According to National Board for ...
(Date:3/28/2017)... ... ... Public relations pros work hard to earn placements and build a ... results are clear, much of PR is hard to quantify. Goal-setting and measurement are ... firms should always take an all-inclusive approach that takes both traditional and non-traditional factors ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... This morning,s research on ... The Medicines Co. (NASDAQ: MDCO), Ironwood Pharmaceuticals Inc. ... Supernus Pharmaceuticals Inc. (NASDAQ: SUPN ). ... which is governed by the same governing framework ... industry are wholesalers, retailers, pharmacies, and benefit managers. Learn ...
(Date:3/28/2017)... , March 28, 2017  AcelRx Pharmaceuticals, ... on the development and commercialization of innovative therapies ... that the European Medicines Agency (EMA) has notified ... 30 mcg) Marketing Authorisation Application (MAA) has passed ... MAA is underway. The MAA for ARX-04 (known ...
(Date:3/28/2017)... FRANCISCO , March 28, 2017 ...  is expected to reach a value of USD 4.5 ... Grand View Research, Inc. Proper closure of injured tissues ... structure and function. Postoperative leakages occur in 3% to ... complication. They are responsible for one third of postoperative ...
Breaking Medicine Technology: